Growth Metrics

Corvus Pharmaceuticals (CRVS) Amortizatization of Intangibles (2022 - 2025)

Corvus Pharmaceuticals has reported Amortizatization of Intangibles over the past 4 years, most recently at $261000.0 for Q4 2025.

  • Quarterly results put Amortizatization of Intangibles at $261000.0 for Q4 2025, up 7.85% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (up 17.88% YoY), and the annual figure for FY2025 was $1.3 million, up 17.88%.
  • Amortizatization of Intangibles for Q4 2025 was $261000.0 at Corvus Pharmaceuticals, down from $459000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for CRVS hit a ceiling of $524000.0 in Q3 2024 and a floor of -$83000.0 in Q3 2022.
  • Median Amortizatization of Intangibles over the past 4 years was $243500.0 (2023), compared with a mean of $221875.0.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 545.0% in 2023 and later plummeted 42.8% in 2024.
  • Corvus Pharmaceuticals' Amortizatization of Intangibles stood at $158000.0 in 2022, then decreased by 19.62% to $127000.0 in 2023, then skyrocketed by 90.55% to $242000.0 in 2024, then increased by 7.85% to $261000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $261000.0 (Q4 2025), $459000.0 (Q3 2025), and $334000.0 (Q2 2025) per Business Quant data.